4
Changes in Ownership
Protagenic Therapeutics, Inc.\new Filed Acc 0001144204-08-006888
Options or other derivatives
- Chief Financial Officer acquired 27,042 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
HARVEY DANIEL · Chief Financial Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2008-02-04 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +13,521 | 13,521 | D |
| 2008-02-04 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +13,521 | 13,521 | D |
Loading xslF345X02/v102281_ex.xml…